Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted delivery of therapeutic agents to the heart
Susmita Sahoo, Taro Kariya, Kiyotake Ishikawa
Nature Reviews Cardiology (2021) Vol. 18, Iss. 6, pp. 389-399
Open Access | Times Cited: 100

Showing 26-50 of 100 citing articles:

Cell-Specific mRNA Therapeutics for Cardiovascular Diseases and Regeneration
Raj Kishore, Ajit Magadum
Journal of Cardiovascular Development and Disease (2024) Vol. 11, Iss. 2, pp. 38-38
Open Access | Times Cited: 5
Navigating cancer therapy induced cardiotoxicity: From pathophysiology to treatment innovations
Jessica Tetterton-Kellner, Brian C. Jensen, Juliane Nguyen
Advanced Drug Delivery Reviews (2024) Vol. 211, pp. 115361-115361
Closed Access | Times Cited: 5
Bioderived Nanoparticles for Cardiac Repair
Xiaolin Cui, Jiacheng Guo, Peiyu Yuan, et al.
ACS Nano (2024) Vol. 18, Iss. 36, pp. 24622-24649
Closed Access | Times Cited: 5
Innovative Approaches to Boost Mesenchymal Stem Cells Efficacy in Myocardial Infarction Therapy
Chuanfeng An, Yuan Zhao, Lipeng Guo, et al.
Materials Today Bio (2025) Vol. 31, pp. 101476-101476
Open Access
The Proteomic Landscape of the Coronary Accessible Heart Cell Surfaceome
Iasmin Inocencio, Alin Rai, D. Donner, et al.
PROTEOMICS (2025)
Closed Access
An Injectable Multifunctional Nanosweeper Eliminates Cardiac Mitochondrial DNA to Reduce Inflammation
Yi‐Jing Li, Xiumeng Hua, Yahui Zhao, et al.
Advanced Healthcare Materials (2025)
Open Access
Drug delivery to the myocardium

Drug delivery (2025), pp. 243-262
Open Access
Identification of splenic IRF7 as a nanotherapy target for tele-conditioning myocardial reperfusion injury
Qiang Long, Kristina Rabi, Yu Cai, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Therapeutic drug delivery system for ischemic heart disease based on hydrogel carriers
Yufeng He, Jun Tang, Chengxi Wu, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106782-106782
Closed Access
Nanomedicines for cardiovascular diseases: lessons learned and pathways forward
Yufei Mao, X.F. Shi, Patricia Sun, et al.
Biomaterials (2025), pp. 123271-123271
Closed Access
Cardiac Tissue Engineering Using Stimuli‐Responsive Biomaterials for the Targeted Therapy of Myocardial Infarction
Zarin Tasnim Tisha, Kazi Tasnuva Alam, Tanvir Ahmed
MedComm – Biomaterials and Applications (2025) Vol. 4, Iss. 1
Open Access
AAV9-cBIN1 gene therapy rescues chronic heart failure due to ischemic cardiomyopathy in a canine model
Muhammad S. Khan, Douglas Smego, Jing Li, et al.
Communications Medicine (2025) Vol. 5, Iss. 1
Open Access
Development of a Decellularized Extracellular Matrix-Derived Wet Adhesive for Sustained Drug Delivery and Enhanced Wound Healing
Xinming Wang, Haonan Zhang, Weichang Xie, et al.
Materials Today Bio (2025), pp. 101734-101734
Open Access
Modified mRNA Treatment Restores Cardiac Function in Desmocollin-2–Deficient Mouse Models of Arrhythmogenic Right Ventricular Cardiomyopathy
Yan Zou, Jing Lü, Zhipeng Lian, et al.
Circulation (2025)
Closed Access
Plasma exosomes generated by ischaemic preconditioning are cardioprotective in a rat heart failure model
Zhaofei Luo, Xudong Hu, Chao Wu, et al.
British Journal of Anaesthesia (2022) Vol. 130, Iss. 1, pp. 29-38
Open Access | Times Cited: 21
Investigating Novel Therapeutic Approaches for Idiopathic Short Stature: Targeting siRNA and Growth Hormone Delivery to the Growth Plate Using Exosome Nanoparticles
Jinghong Yuan, Yameng Wang, Yanzhe Huang, et al.
Advanced Science (2024) Vol. 11, Iss. 24
Open Access | Times Cited: 4
Small extracellular vesicle-mediated CRISPR-Cas9 RNP delivery for cardiac-specific genome editing
Dasom Mun, Jiyoung Kang, Hyoeun Kim, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 798-810
Closed Access | Times Cited: 4
Biomimetic Nanoparticles for Basic Drug Delivery
Andrey Tikhonov, Artyom Kachanov, Alexandra Yudaeva, et al.
Pharmaceutics (2024) Vol. 16, Iss. 10, pp. 1306-1306
Open Access | Times Cited: 4
LMNA-related cardiomyopathy: From molecular pathology to cardiac gene therapy
Ze Wang, Jiahao Wu, Zhongwei Lv, et al.
Journal of Advanced Research (2025)
Open Access
The CathPilot: A Novel Approach for Accurate Interventional Device Steering and Tracking
James J. Zhou, Amaar Quadri, Alykhan Sewani, et al.
IEEE/ASME Transactions on Mechatronics (2022) Vol. 27, Iss. 6, pp. 5812-5823
Open Access | Times Cited: 16
Nanoparticle Based Cardiac Specific Drug Delivery
Dong Li, Yura Son, Michelle Jang, et al.
Biology (2023) Vol. 12, Iss. 1, pp. 82-82
Open Access | Times Cited: 10
Therapeutic potentials of stem cell–derived exosomes in cardiovascular diseases
Saiprahalad Mani, Narasimman Gurusamy, Thennavan Ulaganathan, et al.
Experimental Biology and Medicine (2023) Vol. 248, Iss. 5, pp. 434-444
Open Access | Times Cited: 10
MST1: A future novel target for cardiac diseases
Yingchun Shao, Yanhong Wang, Li Sun, et al.
International Journal of Biological Macromolecules (2023) Vol. 239, pp. 124296-124296
Closed Access | Times Cited: 10
Gene editing innovations and their applications in cardiomyopathy research
Eirini Kyriakopoulou, Thomas Monnikhof, Eva van Rooij
Disease Models & Mechanisms (2023) Vol. 16, Iss. 5
Open Access | Times Cited: 10
Stem Cell-Based Therapy and Cell-Free Therapy as an Alternative Approach for Cardiac Regeneration
Iwona Deszcz
Stem Cells International (2023) Vol. 2023, pp. 1-17
Open Access | Times Cited: 9

Scroll to top